ARSZX | VSIAX | ARSZX / VSIAX | |
Total Expense Ratio | 0.98 | 0.07 | 1,400% |
Annual Report Gross Expense Ratio | 0.98 | 0.07 | 1,400% |
Fund Existence | 8 years | 14 years | - |
Gain YTD | 3.792 | 2.386 | 159% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 5000000 | 3000 | 166,667% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 354M | 55.6B | 1% |
Annual Yield % from dividends | 0.51 | 2.11 | 24% |
Returns for 1 year | 0.01 | 3.38 | 0% |
Returns for 3 years | 9.52 | 24.95 | 38% |
Returns for 5 years | 52.59 | 83.76 | 63% |
Returns for 10 years | N/A | 98.90 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
RYLD | 14.85 | 0.02 | +0.13% |
Global X Russell 2000 Covered Call ETF | |||
CSD | 87.81 | N/A | N/A |
Invesco S&P Spin-Off ETF | |||
JDOC | 51.00 | N/A | N/A |
JPMorgan Healthcare Leaders ETF | |||
RSPA | 50.53 | -0.11 | -0.22% |
Invesco S&P 500 Eq Wght Inc Adv ETF | |||
FXG | 63.89 | -0.79 | -1.22% |
First Trust Cnsmr Staples AlphaDEX® ETF |